N-[6-(2,5-二氫-2,5-二氧代-1H-吡咯-1-基)-1-氧代己基]-L-纈氨酰-N5-(氨基甲?;?-N-[4-(羥甲基)苯基]-L-鳥氨酰胺抑制劑MC-Val-Cit-PAB is a cathepsin cleavable ADC linker that is used for making antibody-drug conjugate. FDA approved drugs such as brentuximab vedotin use this linker.
產品名稱: | N-[6-(2,5-二氫-2,5-二氧代-1H-吡咯-1-基)-1-氧代己基]-L-纈氨酰-N5-(氨基甲?;?-N-[4-(羥甲基)苯基]-L-鳥氨酰胺 | ||
英文名: | MC-Val-Cit-PAB | ||
CAS NO.: | 159857-80-4 | ||
分子式: | C28H40N6O7 | ||
分子量: | 572.653206825256 | ||
產品品牌: | targetmol | ||
產品規格: | 5 mg |